Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Skin and Connective Tissue Diseases

Digestive System Diseases

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Gland and Hormone Related Diseases

Symptoms and General Pathology

Rare Diseases

Lung Neoplasms

Breast Neoplasms

Colorectal Neoplasms

Ovarian Neoplasms

Endocrine Gland Neoplasms

Neoplastic Cells, Circulating

Breast Diseases

Skin Diseases

Intestinal Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Colonic Diseases

Intestinal Diseases

Rectal Diseases

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Ovarian Diseases

Adnexal Diseases

Genital Diseases, Female

Genital Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Genital Neoplasms, Female

Urogenital Neoplasms

Endocrine System Diseases

Gonadal Disorders

Ovarian Cancer

Patients who have one of the Neoplasms stated above under "conditions". Blood samples will be taken.

Patients with a benign tumor or an inflammatory disease - to be matched by age and affected organ with a patient with a malignant disease.

Blood samples will be taken.

People/patients who have no known disease at time of blood sampling or are admitted to the hospital for minor interventions and have no inflammatory disease.

Blood samples will be taken.

Blood sample is collected during routine blood collection by a medical doctor. No more than 60ml (max.) at one timepoint.

Blood collection

Robert Zeillinger, Prof. Dr.

Eva Obermayr, PhD

Jalid Sehouli, Prof.Dr.

Ioana Braicu, Dr.

Robert Zeillinger, Prof.Dr.

Establishment of a tumor bank, consisting of blood samples of tumor patients and healthy people as controls. The blood samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank.

Recent progress in diagnosis and therapy of cancer diseases can be ascribed mainly to translational research. The relevance of "translational oncology" will only increase in the future -"From bench to bedside" - the swift implementation of new science research results in clinical studies in order to expedite progress in clinical cancer therapy for the benefit of the patient.

Its almost a matter of course in the medical science today to collect biological samples together with clinical information thereby creating the foundation for future excellent fundamental research.

The aim of this tumor bank is to consist of biological samples (together with a tissue bank - see EK 260/2003) and isolates of tumor patients and healthy people as controls. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank. The content of the tumor bank can provide essential material for current and future research (e.g. analyses of prognostic or predictive tumor markers; genetically analysis (polymorphism, mutation, hypermethylation; verification and characterisation of disseminated tumor cells).

Establishment of a Tumor Bank for Blood Samples

Establishment of a Blood Sample Bank in the Field of Gynaecological Oncology.

Medical University of Vienna

Prof. Dr.

Spots Global Cancer Trial Database for neoplasms of the female genitalia